{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:09:06Z","timestamp":1782191346440,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11030-024-10993-8","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T06:02:07Z","timestamp":1728453727000},"page":"2305-2321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Taiwan Chingguan Yihau may improve post-COVID-19 respiratory complications through PI3K\/AKT, HIF-1, and TNF signaling pathways revealed by network pharmacology analysis"],"prefix":"10.1007","volume":"29","author":[{"given":"Dung Tam Nguyen","family":"Huynh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hien Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ming","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"issue":"1","key":"10993_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu B, Huang S, Yin L (2021) The cytokine storm and COVID-19. J Med Virol 93(1):250\u2013256","journal-title":"J Med Virol"},{"issue":"11","key":"10993_CR2","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.3390\/vaccines10111926","volume":"10","author":"VP Chavda","year":"2022","unstructured":"Chavda VP, Bezbaruah R, Deka K, Nongrang L, Kalita T (2022) The delta and omicron variants of SARS-CoV-2: what we know so far. Vaccines 10(11):1926","journal-title":"Vaccines"},{"issue":"2","key":"10993_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S2213-2600(21)00031-X","volume":"9","author":"P Venkatesan","year":"2021","unstructured":"Venkatesan P (2021) NICE guideline on long COVID. Lancet Respir Med 9(2):129","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10993_CR4","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/ptr.7436","volume":"36","author":"A Bardel\u010d\u00edkov\u00e1","year":"2022","unstructured":"Bardel\u010d\u00edkov\u00e1 A, Miro\u0161\u0161ay A, \u0160olt\u00fds J, Moj\u017ei\u0161 J (2022) Therapeutic and prophylactic effect of flavonoids in post-COVID-19 therapy. Phytother Res 36(5):2042\u20132060","journal-title":"Phytother Res"},{"key":"10993_CR5","doi-asserted-by":"crossref","unstructured":"Cutler DM. The economic cost of long COVID: an update: Harvard University 2022. https:\/\/scholar.harvard.edu\/cutler\/news\/long-covid.","DOI":"10.1001\/jamahealthforum.2022.1809"},{"key":"10993_CR6","doi-asserted-by":"publisher","first-page":"e01041","DOI":"10.1016\/j.idcr.2020.e01041","volume":"23","author":"MA Alhiyari","year":"2021","unstructured":"Alhiyari MA, Ata F, Alghizzawi MI, Bilal AB, Abdulhadi AS, Yousaf Z (2021) Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection. IDCases 23:e01041","journal-title":"IDCases"},{"issue":"10","key":"10993_CR7","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.jiph.2022.08.007","volume":"15","author":"D Maranatha","year":"2022","unstructured":"Maranatha D, Hasan H, Bakhtiar A, Widyoningroem A, Aryati (2022) Association of TNF-\u03b1, TGF-\u03b21, amphiregulin, IL-2, and EGFR with pulmonary fibrosis in COVID-19. J Infect Public Health 15(10):1072\u20135","journal-title":"J Infect Public Health"},{"issue":"1","key":"10993_CR8","doi-asserted-by":"publisher","first-page":"100221","DOI":"10.1016\/j.phyplu.2022.100221","volume":"2","author":"S Beigh","year":"2022","unstructured":"Beigh S, Rehman MU, Khan A, Patil BR, Makeen HA, Rasool S et al (2022) Therapeutic role of flavonoids in lung inflammatory disorders. Phytomed Plus 2(1):100221","journal-title":"Phytomed Plus"},{"issue":"3","key":"10993_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/biof.1713","volume":"47","author":"SA Hosseini","year":"2021","unstructured":"Hosseini SA, Zahedipour F, Sathyapalan T, Jamialahmadi T, Sahebkar A (2021) Pulmonary fibrosis: therapeutic and mechanistic insights into the role of phytochemicals. BioFactors 47(3):250\u2013269","journal-title":"BioFactors"},{"key":"10993_CR10","doi-asserted-by":"publisher","first-page":"111037","DOI":"10.1016\/j.biopha.2020.111037","volume":"133","author":"K-C Tsai","year":"2021","unstructured":"Tsai K-C, Huang Y-C, Liaw C-C, Tsai C-I, Chiou C-T, Lin C-J et al (2021) A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: a bedside-to-bench study. Biomed Pharmacother 133:111037","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10993_CR11","doi-asserted-by":"publisher","first-page":"100663","DOI":"10.1016\/j.xcrm.2022.100663","volume":"3","author":"C Schulthei\u00df","year":"2022","unstructured":"Schulthei\u00df C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes S-S et al (2022) The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med 3(6):100663","journal-title":"Cell Rep Med"},{"issue":"D1","key":"10993_CR12","doi-asserted-by":"publisher","first-page":"D1197","DOI":"10.1093\/nar\/gkaa1063","volume":"49","author":"S Fang","year":"2021","unstructured":"Fang S, Dong L, Liu L, Guo J, Zhao L, Zhang J et al (2021) HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine. Nucleic Acids Res 49(D1):D1197\u2013D1206","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10993_CR13","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):42717","journal-title":"Sci Rep"},{"issue":"D1","key":"10993_CR14","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"S Kim","year":"2020","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S et al (2020) PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res 49(D1):D1388\u2013D1395","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10993_CR15","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkaa891","volume":"49","author":"AP Davis","year":"2020","unstructured":"Davis AP, Grondin CJ, Johnson RJ, Sciaky D, Wiegers J, Wiegers TC et al (2020) Comparative toxicogenomics database (CTD): update 2021. Nucleic Acids Res 49(D1):D1138\u2013D1143","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10993_CR16","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2020","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S et al (2020) The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res 49(D1):D605\u2013D612","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10993_CR17","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u20132504","journal-title":"Genome Res"},{"issue":"8","key":"10993_CR18","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2019","unstructured":"Ge SX, Jung D, Yao R (2019) ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36(8):2628\u20132629","journal-title":"Bioinformatics"},{"key":"10993_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bax028","author":"S Fishilevich","year":"2017","unstructured":"Fishilevich S, Nudel R, Rappaport N, Hadar R, Plaschkes I, Iny Stein T et al (2017) GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database. https:\/\/doi.org\/10.1093\/database\/bax028","journal-title":"Database"},{"key":"10993_CR20","doi-asserted-by":"publisher","first-page":"W270","DOI":"10.1093\/nar\/gkr366","volume":"39","author":"A Grosdidier","year":"2011","unstructured":"Grosdidier A, Zoete V, Michielin O (2011) SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res 39:W270-7. https:\/\/doi.org\/10.1093\/nar\/gkr366","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10993_CR21","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1002\/jcc.21797","volume":"32","author":"A Grosdidier","year":"2011","unstructured":"Grosdidier A, Zoete V, Michielin O (2011) Fast docking using the CHARMM force field with EADock DSS. J Comput Chem 32(10):2149\u20132159","journal-title":"J Comput Chem"},{"issue":"1","key":"10993_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H et al (2000) The protein data bank. Nucleic Acids Res 28(1):235\u2013242","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10993_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y","volume":"38","author":"MF Sanner","year":"1996","unstructured":"Sanner MF, Olson AJ, Spehner JC (1996) Reduced surface: an efficient way to compute molecular surfaces. Biopolymers 38(3):305\u2013320","journal-title":"Biopolymers"},{"issue":"13","key":"10993_CR24","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC et al (2004) UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612","journal-title":"J Comput Chem"},{"issue":"20","key":"10993_CR25","doi-asserted-by":"publisher","first-page":"11821","DOI":"10.1039\/D0RA07035A","volume":"11","author":"Z Wu","year":"2021","unstructured":"Wu Z, Chen X, Ni W, Zhou D, Chai S, Ye W et al (2021) The inhibition of Mpro, the primary protease of COVID-19, by Poria cocos and its active compounds: a network pharmacology and molecular docking study. RSC Adv 11(20):11821\u201311843","journal-title":"RSC Adv"},{"key":"10993_CR26","doi-asserted-by":"publisher","first-page":"273504","DOI":"10.1093\/ecam\/nem035","volume":"5","author":"C-H Hsu","year":"2008","unstructured":"Hsu C-H, Hwang K-C, Chao C-L, Chang SGN, Ho M-S, Lin J-G et al (2008) An evaluation of the additive effect of natural herbal medicine on SARS or SARS-like infectious diseases in 2003: A randomized, double-blind, and controlled pilot study. Evid-Based Complement Altern Med 5:273504","journal-title":"Evid-Based Complement Altern Med"},{"issue":"06","key":"10993_CR27","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1142\/S0192415X06004405","volume":"34","author":"C-H Hsu","year":"2006","unstructured":"Hsu C-H, Hwang K-C, Chao C-L, Chang SG, Ker C-C, Chien L-C et al (2006) The lesson of supplementary treatment with Chinese medicine on severe laboratory-confirmed SARS patients. Am J Chin Med 34(06):927\u2013935","journal-title":"Am J Chin Med"},{"key":"10993_CR28","doi-asserted-by":"publisher","first-page":"58533","DOI":"10.3389\/fphar.2020.585331","volume":"11","author":"FF Lem","year":"2021","unstructured":"Lem FF, Opook F, Lee DJH, Chee FT, Lawson FP, Chin SN (2021) Molecular mechanism of action of repurposed drugs and traditional chinese medicine used for the treatment of patients infected with COVID-19: a systematic scoping review. Front Pharmacol 11:58533","journal-title":"Front Pharmacol"},{"issue":"2","key":"10993_CR29","doi-asserted-by":"publisher","first-page":"100407","DOI":"10.1016\/j.imr.2020.100407","volume":"9","author":"L Ang","year":"2020","unstructured":"Ang L, Lee HW, Choi JY, Zhang J, Lee MS (2020) Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines. Integr Med Res 9(2):100407","journal-title":"Integr Med Res"},{"issue":"9","key":"10993_CR30","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s11655-020-3426-7","volume":"26","author":"J-b Wang","year":"2020","unstructured":"Wang J-b, Wang Z-x, Jing J, Zhao P, Dong J-h, Zhou Y-f et al (2020) Exploring an integrative therapy for treating COVID-19: a randomized controlled trial. Chin J Integr Med 26(9):648\u201355","journal-title":"Chin J Integr Med"},{"key":"10993_CR31","doi-asserted-by":"publisher","first-page":"153930","DOI":"10.1016\/j.phymed.2022.153930","volume":"98","author":"PK Mukherjee","year":"2022","unstructured":"Mukherjee PK, Efferth T, Das B, Kar A, Ghosh S, Singha S et al (2022) Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications. Phytomedicine 98:153930","journal-title":"Phytomedicine"},{"issue":"5","key":"10993_CR32","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/vaccines9050497","volume":"9","author":"HC Maltezou","year":"2021","unstructured":"Maltezou HC, Pavli A, Tsakris A (2021) Post-COVID syndrome: an insight on its pathogenesis. Vaccines 9(5):497","journal-title":"Vaccines"},{"issue":"2","key":"10993_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","volume":"23","author":"S Mehandru","year":"2022","unstructured":"Mehandru S, Merad M (2022) Pathological sequelae of long-haul COVID. Nat Immunol 23(2):194\u2013202","journal-title":"Nat Immunol"},{"key":"10993_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.668407","author":"Z-H Yang","year":"2021","unstructured":"Yang Z-H, Wang B, Ma Q, Wang L, Lin Y-X, Yan H-F et al (2021) Potential mechanisms of action of Chinese patent medicines for COVID-19: a review. Front Pharmcol. https:\/\/doi.org\/10.3389\/fphar.2021.668407","journal-title":"Front Pharmcol"},{"issue":"1","key":"10993_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13020-022-00587-7","volume":"17","author":"X Kang","year":"2022","unstructured":"Kang X, Jin D, Jiang L, Zhang Y, Zhang Y, An X et al (2022) Efficacy and mechanisms of traditional Chinese medicine for COVID-19: a systematic review. Chin Med 17(1):30","journal-title":"Chin Med"},{"key":"10993_CR36","doi-asserted-by":"publisher","first-page":"926901","DOI":"10.3389\/fphar.2022.926901","volume":"13","author":"S Zheng","year":"2022","unstructured":"Zheng S, Xue T, Wang B, Guo H, Liu Q (2022) Application of network pharmacology in the study of the mechanism of action of traditional chinese medicine in the treatment of COVID-19. Front Pharmacol 13:926901","journal-title":"Front Pharmacol"},{"key":"10993_CR37","doi-asserted-by":"publisher","first-page":"117793222211496","DOI":"10.1177\/11779322221149622","volume":"17","author":"HT Nguyen","year":"2023","unstructured":"Nguyen HT, Do VM, Phan TT, Nguyen Huynh DT (2023) The potential of ameliorating COVID-19 and sequelae from Andrographis paniculata via bioinformatics. Bioinform Biol Insights 17:11779322221149622","journal-title":"Bioinform Biol Insights"},{"key":"10993_CR38","doi-asserted-by":"publisher","first-page":"109567","DOI":"10.1016\/j.cbi.2021.109567","volume":"345","author":"SM Jaffal","year":"2021","unstructured":"Jaffal SM, Abbas MA (2021) TRP channels in COVID-19 disease: Potential targets for prevention and treatment. Chem Biol Interact 345:109567","journal-title":"Chem Biol Interact"},{"issue":"1","key":"10993_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.rmed.2014.11.001","volume":"109","author":"E Ternesten-Hass\u00e9us","year":"2015","unstructured":"Ternesten-Hass\u00e9us E, Johansson E-L, Millqvist E (2015) Cough reduction using capsaicin. Respir Med 109(1):27\u201337","journal-title":"Respir Med"},{"issue":"8","key":"10993_CR40","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.biocel.2006.02.003","volume":"38","author":"X Yan","year":"2006","unstructured":"Yan X, Hao Q, Mu Y, Timani KA, Ye L, Zhu Y et al (2006) Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT\/enhancer binding protein. Int J Biochem Cell Biol 38(8):1417\u20131428","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"10993_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.pupt.2010.10.005","volume":"24","author":"D Knight","year":"2011","unstructured":"Knight D, Mutsaers SE, Pr\u00eale CM (2011) STAT3 in tissue fibrosis: is there a role in the lung? Pulm Pharmacol Ther 24(2):193\u2013198","journal-title":"Pulm Pharmacol Ther"},{"key":"10993_CR42","doi-asserted-by":"publisher","first-page":"105295","DOI":"10.1016\/j.psyneuen.2021.105295","volume":"131","author":"N Kappelmann","year":"2021","unstructured":"Kappelmann N, Dantzer R, Khandaker GM (2021) Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology 131:105295","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10993_CR43","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1371\/journal.pone.0000108","volume":"1","author":"N Oikonomou","year":"2006","unstructured":"Oikonomou N, Harokopos V, Zalevsky J, Valavanis C, Kotanidou A, Szymkowski DE et al (2006) Soluble TNF mediates the transition from pulmonary inflammation to fibrosis. PLoS ONE 1(1):e108","journal-title":"PLoS ONE"},{"issue":"3","key":"10993_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3904\/kjim.2014.29.3.281","volume":"29","author":"C-M Lee","year":"2014","unstructured":"Lee C-M, Park JW, Cho W-K, Zhou Y, Han B, Yoon PO et al (2014) Modifiers of TGF-b1 effector function as novel therapeutic targets of pulmonary fibrosis. Korean J Intern Med 29(3):281\u2013290","journal-title":"Korean J Intern Med"},{"issue":"4","key":"10993_CR45","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.21037\/apm-20-1384","volume":"10","author":"M-X Yu","year":"2021","unstructured":"Yu M-X, Song X, Ma X-Q, Hao C-X, Huang J-J, Yang W-H (2021) Investigation into molecular mechanisms and high-frequency core TCM for pulmonary fibrosis secondary to COVID-19 based on network pharmacology and data mining. Ann Palliat Med 10(4):3960\u20133975","journal-title":"Ann Palliat Med"},{"key":"10993_CR46","doi-asserted-by":"publisher","first-page":"8887017","DOI":"10.1155\/2020\/8887017","volume":"2020","author":"B Qiao","year":"2020","unstructured":"Qiao B, Wu Y, Li X, Xu Z, Duan W, Hu Y et al (2020) A Network pharmacology approach to explore the potential mechanisms of Yifei Sanjie formula in treating pulmonary fibrosis. Evid-Based Complement Altern Med 2020:8887017","journal-title":"Evid-Based Complement Altern Med"},{"key":"10993_CR47","doi-asserted-by":"publisher","first-page":"636298","DOI":"10.3389\/fmed.2021.636298","volume":"8","author":"M Liu","year":"2021","unstructured":"Liu M, Lv F, Huang Y, Xiao K (2021) Follow-up study of the chest CT characteristics of COVID-19 survivors seven months after recovery. Front Med 8:636298","journal-title":"Front Med"},{"key":"10993_CR48","doi-asserted-by":"publisher","first-page":"175346662092680","DOI":"10.1177\/1753466620926800","volume":"14","author":"X-Y Chen","year":"2020","unstructured":"Chen X-Y, Yan B-X, Man X-Y (2020) TNF\u03b1 inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis. Ther Adv Respir Dis 14:1753466620926800","journal-title":"Ther Adv Respir Dis"},{"issue":"3","key":"10993_CR49","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s11033-022-07166-x","volume":"49","author":"V Ablamunits","year":"2022","unstructured":"Ablamunits V, Lepsy C (2022) Blocking TNF signaling may save lives in COVID-19 infection. Mol Biol Rep 49(3):2303\u20132309","journal-title":"Mol Biol Rep"},{"issue":"8","key":"10993_CR50","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1111\/febs.15871","volume":"289","author":"A Nath","year":"2022","unstructured":"Nath A, Johnson TP (2022) Mechanisms of viral persistence in the brain and therapeutic approaches. FEBS J 289(8):2145\u20132161","journal-title":"FEBS J"},{"issue":"3","key":"10993_CR51","first-page":"675","volume":"166","author":"N Hemmat","year":"2021","unstructured":"Hemmat N, Asadzadeh Z, Ahangar NK, Alemohammad H, Najafzadeh B, Derakhshani A et al (2021) The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV. Adv Virol 166(3):675\u2013696","journal-title":"Adv Virol"},{"issue":"12","key":"10993_CR52","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/s41401-020-00554-8","volume":"41","author":"ZO Serebrovska","year":"2020","unstructured":"Serebrovska ZO, Chong EY, Serebrovska TV, Tumanovska LV, Xi L (2020) Hypoxia, HIF-1\u03b1, and COVID-19: from pathogenic factors to potential therapeutic targets. Acta Pharmacol Sin 41(12):1539\u20131546","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"10993_CR53","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.micinf.2016.10.004","volume":"19","author":"N Vassilaki","year":"2017","unstructured":"Vassilaki N, Frakolaki E (2017) Virus\u2013host interactions under hypoxia. Microbes Infect 19(3):193\u2013203","journal-title":"Microbes Infect"},{"issue":"1","key":"10993_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12950-020-00263-3","volume":"17","author":"M Jahani","year":"2020","unstructured":"Jahani M, Dokaneheifard S, Mansouri K (2020) Hypoxia: a key feature of COVID-19 launching activation of HIF-1 and cytokine storm. J Inflamm 17(1):33","journal-title":"J Inflamm"},{"issue":"1","key":"10993_CR55","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41392-021-00726-w","volume":"6","author":"M Tian","year":"2021","unstructured":"Tian M, Liu W, Li X, Zhao P, Shereen MA, Zhu C et al (2021) HIF-1\u03b1 promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19. Signal Transduct Target Ther 6(1):308","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"10993_CR56","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/ph15070794","volume":"15","author":"Y-C Lu","year":"2022","unstructured":"Lu Y-C, Tseng L-W, Huang Y-C, Yang C-W, Chen Y-C, Chen H-Y (2022) The potential complementary role of using Chinese herbal medicine with western medicine in treating COVID-19 patients: pharmacology network analysis. Pharmaceuticals 15(7):794","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10993_CR57","doi-asserted-by":"publisher","first-page":"151908","DOI":"10.1016\/j.acthis.2022.151908","volume":"124","author":"Y Rasmi","year":"2022","unstructured":"Rasmi Y, Hatamkhani S, Naderi R, Shokati A, Nayeb Zadeh V, Hosseinzadeh F et al (2022) Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection. Acta Histochem 124(5):151908","journal-title":"Acta Histochem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10993-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-10993-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10993-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T13:02:45Z","timestamp":1747314165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-10993-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10993"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-10993-8","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]},"assertion":[{"value":"8 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}